Impact of Ambulatory Management for Primary Spontaneous Pneumothorax in the Emergency Department on Quality of Life

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorUniversity Hospital, Strasbourg, France

About this trial

Outpatient treatment of Primary Spontaneous Pneumothorax (PSP) compared to usual inpatient management could improve quality of care and represent a more efficient, generalizable and sustainable strategy.

This multicenter, cluster-controlled, randomized interventional study with stepped wedge implementation will evaluate the impact on quality of life (between inclusion, after drain placement, and 6 months) of an ambulatory strategy for the management of large abundance primary spontaneous pneumothorax in the emergency department, compared with usual care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18 to 50 years presenting to the emergency department with a 1st episode of right or left primary spontaneous pneumothorax (PSP) of large abundance diagnosed by chest X-ray or CT scan defined according to British Thoracic Society (BTS) recommendations as a detachment greater than 2 cm over the entire height of the axillary line.

Patient living less than an hour from hospital and able to be accompanied for the first 48 hours

Patient able to understand the aims and risks of the research and to give informed, dated and signed consent

Patient with Internet access and able to complete online questionnaires

Disqualifiers

Small pneumothorax (≤ 2cm)

Suffocating pneumothorax defined by the presence of signs of respiratory distress or hemodynamic failure with indication for emergency exsufflation

Patient on emergency oxygen or long-term oxygen therapy

Traumatic pneumothorax

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ambulatory management

    Other intervention

    * Chest tube drainage in emergency department (Furhmann drain connected to Heimlich valve), connected to suction system at -5 to -10 cm H2O until bubbling stops * Follow-up imaging at 4 hours (chest X-ray or low-dose CT scan, depending on management practices in the centers) * if the pneumothorax is still very large, or if clinical tolerance is unsatisfactory (dyspnea, unrelieved pain, abnormal vital parameters), the patient should be admitted to hospital * if the lung is in the process of reattachment and a minimal detachment persists, and clinical tolerance is good (assessed on vital parameters, with oxygen saturation above 98%, good hemodynamic stability and pain relieved by analgesics), the patient may be discharged home.

  • Standard Care

    Other intervention

    Hospitalisation in a hospital department (pulmonology, thoracic surgery, short-stay emergency unit, critical care, according to the usual pathway of the center in which the patient is included). In-hospital monitoring until complete resolution of pneumothorax and drain removal (average 4-6 days).

Treatment groups

386 Participants
are divided into 2 treatment groups
Group A: Standard careActive comparator 1 intervention
Group B: Ambulatory managementExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Quality of life at 6 months

Evaluate the impact on quality of life (between inclusion, after drain placement, and 6 months) of an ambulatory strategy for the management of large abundance primary spontaneous pneumothorax in the emergency department, compared with usual care, using the Short Form (36) Health Survey (The lower the score the more disability)

Time frame
6 months

Secondary outcomes

1

Success rate of the strategy as measured by pulmonary expansion (lung reattachment on X-ray / CT scan) the latest by the investigator who performed the drainage procedure

Time frame
Day 6
2

Proportion of patients having benefited from an exclusive outpatient management (patients not requiring hospitalisation during the ambulatory approach)

Time frame
Day 6
3

Assessment of Pain

Pain assessed on a numerical scale (rated from 0 to 10), 0 being the lowest pain and 10 being the maximum pain

Time frame
Day 0, Day 2, Day 4, Day 6 and monthly
4

Assessment of Dyspnea according to the mMRC classification

mMRC classification (0 to 4), 0 being no discomfort and 4 shortness of breath for simple acts of daily living.

Time frame
Day 0, Day 2, Day 4, Day 6 and monthly

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: